Overview
Minghao Li practices practicing medicine in Zhongshan, China.
Li is highly rated in 1 condition, according to our data. Their clinical expertise encompasses Neurotoxicity Syndromes, Acute Lymphoblastic Leukemia (ALL), Leukemia, and Non-Hodgkin Lymphoma.
They are actively involved in clinical research, co-authoring 27 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Minghao Li
Is Minghao Li a top-rated expert for Neurotoxicity Syndromes?
MediFind is an objective health platform that identifies experts based on real-world data. Minghao Li is classified as an Advanced expert for Neurotoxicity Syndromes, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Minghao Li participate in research or clinical trials?
Yes. Minghao Li has published 27 articles and abstracts on conditions like Neurotoxicity Syndromes. You can view a list of Minghao Li's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Neurotoxicity Syndromes
- Experienced
- Acute Lymphoblastic Leukemia (ALL)
- LeukemiaLi isExperienced. Learn about Leukemia.
- Non-Hodgkin LymphomaLi isExperienced. Learn about Non-Hodgkin Lymphoma.